A novel role of topical iodine in skin: Activation of the Nrf2 pathway

https://doi.org/10.1016/j.freeradbiomed.2017.01.011Get rights and content

Highlights

  • Iodine and iodide are capable of activating the Nrf2 pathway in cells and human skin.

  • The enhanced potency of potassium iodide vs. strong iodine solution in activating the system was shown.

  • The involvement of traces of "loosely bound metal" and hydrogen peroxide in the mechanism involved is demonstrated.

  • Iodine and iodide provide protection against UVB-induced damage and a relief under inflamed skin condition.

Abstract

For a long time iodine has been used as an active dermal agent in the treatment of inflammatory, immune-mediated and infectious diseases. Moreover, topical iodine application has been reported to provide protection against sulfur-mustard-induced skin lesions, heat-induced and acid-induced skin burns in both haired guinea-pigs and mouse ear swelling models. However, the exact mechanism of action underlying these benefits of iodine has not yet been elucidated. In the current study, a novel mechanism of action by which iodine provides skin protection and relief, based on its electrophilic nature, is suggested. This study demonstrates that both iodine and iodide are capable of activating the Nrf2 pathway in human skin. As a result, skin protection against UVB-induced damage was acquired and the secretion of pro-inflammatory cytokines (IL-6, IL-8) from LPS-challenged skin was reduced. Iodide role in the enhanced activation of this pathway is demonstrated. The mode of action by which iodine and iodide activate the Nrf2 pathway is discussed.

Introduction

Iodine is a chemical element which has been obtained from seaweeds, fish, and seawater since early 19th century [1], [2]. It is sparingly soluble in water (0.33 g/l at 25 °C) and its solubility can be raised in the presence of iodide ions, such as potassium iodide, to form the tri-iodide ion [1], [3]. In humans, it was used in the treatment of thyroid disorders since it is vital for the biosynthesis of the thyroid hormones, triiodothyronine and thyroxine, which ensure proper metabolism [1], [2], [4]. However, the use of iodine was rapidly extended over time, and is now being used as an active dermal agent in the treatment of inflammatory, immune-mediated and infectious diseases (e.g. psoriasis, eczema, lupus vulgaris, syphilis) [2]. In fact, the use of iodine as a bactericidal, antiseptic agent in wound care has been reported as being effective for more than 150 years [1], [2], [5]. Iodine offers a wide spectrum of antimicrobial activity and is capable of rapidly inhibiting yeasts, molds, protozoa and viruses [1], [6], [7], [8]. Invaded microorganisms are prone to be attacked simultaneously in multiple sites, following iodine treatment, without developing any resistance [1]. The combined activity of iodine on microorganisms' cell wall, membrane and cytoplasm may be detrimental, as iodine binds to proteins, react with C-C bonds in fatty acids and may oxidize disulfide bonds in amino acids (e.g. cysteine, methionine). In addition, it may prevent hydrogen bonding by reacting with N-H groups in arginine, histidine and lysine and preclude hydrogen bonding in nucleic acids (e.g. adenine, cytosine) [1], [7].

Topical iodine application has been reported to provide protection against sulfur-mustard-induced skin lesions, heat-induced and acid-induced skin burns [9], [10] in both haired guinea-pigs and mouse ear swelling models [11]. Surprisingly, the mechanism of action by which iodine provides relief in these cases, as well as for skin immune-mediated and/or inflammatory diseases, is not fully understood and further comprehensive research is required. Although many suggestions have made, including iodine's ability to inhibit apoptosis and/or proteinase activity [10], reduce collagenolytic activity [12], reduce inducible nitric oxide synthase expression [13], depress oxidative-burst effect, and scavenge hydroxyl suppressing the induction of TNF-α and, perhaps, other inflammatory mediators as well [14], additional studies are needed.

Iodine is an oxidizing agent (standard reduction potential at 25 °C, E°=0.536 V) [15] and therefore may affect cellular pathways. Here, we suggest a novel mode of action by which iodine provides skin relief and protects against stress-mediated skin injuries. We hypothesize that iodine is capable of activating the NF-E2-related factor 2 (Nrf2) pathway, due to its electrophilic properties. To the best of our knowledge, it has never been suggested that iodine can activate the Nrf2 pathway and induce phase-II enzymes in skin cells. This is a cytoprotective signaling pathway, which serves as a major intersection for many other signaling pathways that cross-talk with each other and determine cell functionality and fate [16], [17], [18]. Nrf2 is capable of coordinating the cellular response to endogenous as well as exogenous stressors by tight regulation of phase-II protective enzymes [16], [17], [18] which are responsible for the antioxidant response, xenobiotic disposition, inflammatory response, metabolic programming and cell proliferation and survival [19]. The involvement of the Nrf2 pathway in skin is of high importance; playing a role in skin homeostasis and skin renovation and a variety of other skin diseases, e.g. allergic skin inflammation atopic dermatitis, psoriasis, epidermal blistering disease, and vitiligo vulgaris [20]. Pharmacological activation of Nrf2 was demonstrated to be efficient in the prevention of skin carcinogenesis in a variety of animal studies [20]. Moreover, protection against UV-induced cytotoxicity and photo-aging was shown [20].

The classic activation of the Nrf2 pathway is regulated by two cysteine-rich proteins called Keap1 (Kelch-like ECH associated protein1) [21], [22], [23], [24], [25]. Under basal conditions, Nrf2 is anchored to the cytoplasm via the Keap1 actin cytoskeleton binding protein and degraded via the ubiquitin proteasome pathway resulting in Nrf2 half-life of approximately 10–20 min [21], [24], [25], [26], [27]. However, upon oxidative/electrophilic stress conditions, i.e. exogenous or endogenous electrophile or reactive oxygen species, the Keap1 protein is modified, resulting in the suppression of Keap1-mediated proteasomal degradation of Nrf2, thereby causing Nrf2 stabilization with half-life extending to approximately 100–200 min [28], [29], translocation and accumulation in the nucleus [30]. As Nrf2 accumulates in the nucleus, it heterodimerizes with additional proteins (e.g. small Maf proteins), and binds to the antioxidant-response element (ARE), also known as the electrophile-response element (EpRE) in the regulatory sequences of its target genes [16], [31]. As a result, large networks of gene-encoding enzymes and detoxifying proteins, are expressed [32], [33], [34], [35], [36]. In addition, the involvement of many kinases and phosphatases contributes to pathway complications [37], [38], [39], [40]. Additional mechanisms of action were suggested for Nrf2 activation including inhibition of Keap1-Nrf2 interaction by blocking the Keap1 domain [41], methylation/demethylation of CpGs in the promoter regions, acetylation/deacetylation and methylation/demethylation of histones, or targeting of mRNAs by miRNAs [42]. Moreover, certain non-coding RNAs are also capable of influencing Nrf2 [42].

The aim of this study is to investigate whether iodine may obtain its beneficial effects, described above as a dermal protecting agent, at least partially, via activation of the Nrf2 pathway in the skin. In addition, the activation of Nrf2 pathway by iodine was elucidated. Moreover, iodide's (I-) ability to activate the Nrf2 pathway was also reported and discussed.

Section snippets

Materials

All chemicals were of analytical grade and were used as received. Water for preparation of the solutions was purified using a Milli-Q purification system. Iodine was purchased from MERCK Chemicals, Switzerland, potassium iodide was purchased from J.T.Baker Chemicals, USA. Diethylenetriaminepentaacetic acid (DETAPAC) and Tert-Butyl hydroperoxide solution were purchased from Sigma-Aldrich, Israel. NaOH was purchased from FRUTAROM, Israel. Strong iodine solution was prepared by dissolving 5 g of

Skin-cell viability is not affected by iodine and iodide treatments

Keratinocyte viability following 24-h treatment with strong iodine solution (USP) and potassium iodide solution was evaluated by MTT assay. Fig. 1 shows cell viability (%) for treatments ranging from 0 to 750 µM. As can be seen there is no significant difference between the control group (untreated cells), strong iodine solution and potassium iodide, indicating that the concentrations used are nontoxic.

Iodine and iodide demonstrate different potential in activation of Nrf2 pathway in skin

Nrf2 is a redox "master switch" that can turn on the cellular signaling involved in the

Discussion

Activation of the Nrf2 pathway in the skin is a major strategy for maintaining skin redox balance and is highly important for skin redox homeostasis, functionality and repair processes [20]. Moreover, this strategy was proven to be effective under stress conditions, in different skin models and pathologies [20]. The strength of this strategy derived from a few different contributions. First, there is the obvious rationale of utilizing the self-protection mechanisms that skin is equipped with,

Conclusions

This work revealed a novel mode of action by which iodine and iodide operate in human keratinocytes and the skin. We demonstrated that iodine and iodide are capable of activating the Nrf2 pathway, thus providing, protection against UVB-induced damage and a relief under inflamed skin condition. The enhanced potency of potassium iodide vs. strong iodine in activating the system was shown. A possible underlying mechanism of activity for Nrf2 activation was suggested. Further studies are needed to

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Acknowledgments

We thank Dr. Sabine Werner for kindly providing us with Nrf2 knock-out and Nrf2 dominant- negative cell lines and for her generous assistance. Dr. Ron Kohen is affiliated with the Bloom Center of Pharmacy. He is the incumbent of the Richard and Jean Zarbin Chair in Medical Studies at the Hebrew University of Jerusalem. This work was funded by the David and Ines Myers Fund of Cleveland, Ohio, USA; Yissum, the technology transfer company of the Hebrew University (Grant no. 0344809); the Hebrew

References (81)

  • J.D. Hayes et al.

    NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

    Trends Biochem. Sci.

    (2009)
  • E.D. Owuor et al.

    Antioxidants and oxidants regulated signal transduction pathways

    Biochem. Pharmacol.

    (2002)
  • B.G. Richardson et al.

    Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway

    Bioorg. Med. Chem. Lett.

    (2015)
  • Y. Guo et al.

    Epigenetic regulation of Keap1-Nrf2 signaling

    Free Radic. Biol. Med.

    (2015)
  • M. Portugal-Cohen et al.

    Exposure of human keratinocytes to ischemia, hyperglycemia and their combination induces oxidative stress via the enzymes inducible nitric oxide synthase and xanthine oxidase

    J. Dermatol. Sci.

    (2009)
  • F. Lieder et al.

    Identification of UV-protective activators of nuclear factor erythroid-derived 2-related factor 2 (Nrf2) by combining a chemical library screen with computer-based virtual screening

    J. Biol. Chem.

    (2012)
  • P. Wolf et al.

    Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice

    J. Investig. Dermatol.

    (1993)
  • H. Masaki et al.

    Detection of hydrogen peroxide and hydroxyl radicals in murine skin fibroblasts under UVB irradiation

    Biochem. Biophys. Res. Commun.

    (1995)
  • D.R. Bickers et al.

    Oxidative stress in the pathogenesis of skin disease

    J. Investig. Dermatol.

    (2006)
  • M. Ben YehudaGreenwald et al.

    Can nitroxides evoke the Keap1-Nrf2-ARE pathway in skin?

    Free Radic. Biol. Med.

    (2014)
  • T. Satoh et al.

    Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs

    Free Radic. Biol. Med.

    (2013)
  • J. Maier et al.

    Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice

    Biochim. Biophys. Acta (BBA)-Mol. Cell Res.

    (2007)
  • A. Minelli et al.

    Cyclo (His-pro) exerts anti-inflammatory effects by modulating NF-־÷B and Nrf2 signalling

    Int. J. Biochem. Cell Biol.

    (2012)
  • I. Paur et al.

    Degree of roasting is the main determinant of the effects of coffee on NF-־÷B and EpRE

    Free Radic. Biol. Med.

    (2010)
  • R. Checker et al.

    Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kB

    Free Radic. Biol. Med.

    (2012)
  • D.M. Stanbury

    Reduction potentials involving inorganic free radicals in aqueous solution

    Adv. Inorg. Chem.

    (1989)
  • G.P. Bienert et al.

    Membrane transport of hydrogen peroxide

    Biochim. Biophys. Acta (BBA)-Biomembr.

    (2006)
  • R.A. Cooper

    Iodine revisited

    Int. Wound J.

    (2007)
  • R.O. Costa et al.

    Use of potassium iodide in Dermatology: updates on an old drug

    An. Bras. Dermatol.

    (2013)
  • W. Gottardi

    Iodine and Iodine Compounds, Disinfection, Sterilization, and Preservation

    (2001)
  • J.C. Lawrence

    The use of iodine as an antiseptic agent

    J. Wound Care

    (1998)
  • B.A. Saggers et al.

    Polyvinyl-pyrrolidone-iodine: an assessment of antibacterial activity

    J. Hyg.

    (1964)
  • S.S. Block

    Disinfection, Sterilization, and Preservation

    (2001)
  • U. Wormser et al.

    Protective effect of topical iodine preparations upon heat-induced and hydrofluoric acid-induced skin lesions

    Toxicol. Pathol.

    (2002)
  • U. Wormser et al.

    Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions

    Arch. Toxicol.

    (2004)
  • U. Wormser et al.

    Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity

    Arch. Toxicol.

    (2002)
  • A. Nyska et al.

    Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin injury in guinea pigs

    Arch. Toxicol.

    (2001)
  • U. Wormser et al.

    Involvement of tumor necrosis factor-־±in sulfur mustard-induced skin lesion; effect of topical iodine

    Arch. Toxicol.

    (2005)
  • P. Atkins et al.

    Atkins' Physical Chemistry

    (2002)
  • N. Wakabayashi et al.

    When NRF2 talks, who's listening?

    Antioxid. Redox Signal.

    (2010)
  • Cited by (21)

    • Dermal toxicity of sulfur mustard

      2020, Handbook of Toxicology of Chemical Warfare Agents
    View all citing articles on Scopus
    1

    Current address: Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology (ETH) Zurich, CH 8093 Zurich, Switzerland.

    View full text